Synthetic biomaterials for spinal fusion

Area of Science:

• Orthopedic surgery
• Biomaterials science
• Spinal fusion research

Background:

• Spinal fusion is a critical surgical procedure.
• Biomaterials are investigated to enhance spinal fusion success rates.
• Calcium hydroxylapatite (HAP), tricalcium phosphate (TCP), and Bioglass (BG) are potential bone graft substitutes.

Purpose of the Study:

• To evaluate the efficacy of HAP, TCP, and BG in augmenting spinal fusion in a canine model.
• To assess the bone-to-biomaterial interface and resorption characteristics of these materials.
• To determine if combining these biomaterials impacts spinal fusion outcomes.

Main Methods:

• Surgical implantation of HAP, TCP, and BG into the canine spine.
• Histological evaluation of bone integration, biomaterial incorporation, and tissue response.
• Assessment of biomaterial performance both independently and in combination, with and without decortication and autogenous bone.

Main Results:

• HAP and TCP demonstrated continuous bone-to-biomaterial interfaces, with trabecular bone surrounding and incorporating HAP.
• TCP showed minimal resorption, while BG exhibited fibrous encapsulation with some adjacent bone.
• Decortication and autogenous bone enhanced biomaterial incorporation.
• Combined materials showed similar trends to independently implanted ones, with no adverse tissue reactions.

Conclusions:

• HAP and TCP show promise as biomaterials for enhancing spinal fusion due to good bone integration.
• BG demonstrated less favorable integration compared to HAP and TCP in this model.
• The combination of biomaterials did not elicit adverse reactions and maintained observed integration trends.